SG11201501195RA - Rapid method production high purity cancer stem cells and population of high purity cancer stem cells - Google Patents
Rapid method production high purity cancer stem cells and population of high purity cancer stem cellsInfo
- Publication number
- SG11201501195RA SG11201501195RA SG11201501195RA SG11201501195RA SG11201501195RA SG 11201501195R A SG11201501195R A SG 11201501195RA SG 11201501195R A SG11201501195R A SG 11201501195RA SG 11201501195R A SG11201501195R A SG 11201501195RA SG 11201501195R A SG11201501195R A SG 11201501195RA
- Authority
- SG
- Singapore
- Prior art keywords
- stem cells
- high purity
- cancer stem
- purity cancer
- population
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 2
- 201000011510 cancer Diseases 0.000 title 2
- 210000000130 stem cell Anatomy 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0695—Stem cells; Progenitor cells; Precursor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/57—Skin; melanoma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261683477P | 2012-08-15 | 2012-08-15 | |
US201261718643P | 2012-10-25 | 2012-10-25 | |
PCT/US2013/053850 WO2014028274A1 (en) | 2012-08-15 | 2013-08-06 | Rapid method production high purity cancer stem cells and population of high purity cancer stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201501195RA true SG11201501195RA (en) | 2015-05-28 |
Family
ID=50101414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201501195RA SG11201501195RA (en) | 2012-08-15 | 2013-08-06 | Rapid method production high purity cancer stem cells and population of high purity cancer stem cells |
Country Status (12)
Country | Link |
---|---|
US (1) | US20150238586A1 (en) |
EP (1) | EP2885403A4 (en) |
JP (1) | JP2015526087A (en) |
KR (1) | KR20150041149A (en) |
CN (1) | CN105051187A (en) |
AU (1) | AU2013303012B2 (en) |
CA (1) | CA2882095A1 (en) |
GB (1) | GB2519717A (en) |
HK (1) | HK1210498A1 (en) |
IL (1) | IL237205A0 (en) |
SG (1) | SG11201501195RA (en) |
WO (1) | WO2014028274A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2968531A4 (en) * | 2013-03-12 | 2016-12-28 | Neostem Oncology Llc | High purity ovarian cancer stem cells for active autologous immune therapy |
WO2016036319A1 (en) * | 2014-09-04 | 2016-03-10 | Agency For Science, Technology And Research | A method to up-regulate cancer stem cell markers for the generation of antigen specific cytotoxic effector t cells |
US11464838B2 (en) | 2015-04-01 | 2022-10-11 | Colorado State University Research Foundation | Optimized cancer stem cell vaccines |
MA43342A (en) * | 2015-09-30 | 2018-08-08 | Medimmune Ltd | COMPOSITIONS AND METHOD OF INHIBITION OF CANCERY STEM CELLS |
JP6988480B2 (en) * | 2015-12-18 | 2022-01-05 | 日本ゼオン株式会社 | Method for preparing suspension-cultured conditioned adherent cells, method for inducing epithelial-mesenchymal transition of adherent epithelial cells, and utilization thereof |
EP3208331A1 (en) * | 2016-02-17 | 2017-08-23 | PromoCell bioscience alive GmbH Biomedizinische Produkte | Chemically defined medium for the culture of cancer stem cell (csc) containing cell populations |
EP3722417A4 (en) * | 2017-12-08 | 2021-09-22 | Kyo Diagnostics K.K. | Cancer spheroid production method and method for selecting colon cancer patients |
US20210018492A1 (en) * | 2018-03-13 | 2021-01-21 | Corning Incorporated | High density 3d hepatocyte spheroid platform for drug adme studies |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6984522B2 (en) * | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
AU2003300184B8 (en) | 2002-12-30 | 2009-12-03 | 3M Innovative Properties Company | Immunostimulatory combinations |
EP1674479A1 (en) * | 2004-12-22 | 2006-06-28 | Memorial Sloan-Kettering Cancer Center | Modulation of Fc Gamma receptors for optimizing immunotherapy |
US7935804B2 (en) | 2006-03-01 | 2011-05-03 | Aduro Biotech | Engineered Listeria and methods of use thereof |
US7993648B2 (en) * | 2006-05-03 | 2011-08-09 | The Regents of the Universitry of Colorado | Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody |
JP5427027B2 (en) * | 2006-05-03 | 2014-02-26 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・コロラド,ア・ボディー・コーポレイト | CD40 agonist antibody / type I interferon synergistic adjuvant conjugates, conjugates comprising the same, and their use as therapeutics to enhance cellular immunity |
WO2007145901A1 (en) * | 2006-06-06 | 2007-12-21 | University Of Tennessee Research Foundation | Compositions enriched in neoplastic stem cells and methods comprising same |
CA2700573C (en) * | 2006-09-26 | 2016-11-22 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
JP2008182912A (en) * | 2007-01-29 | 2008-08-14 | Nippon Kayaku Co Ltd | Method for culturing cancer stem cell and cancer stem cell |
JP2011529080A (en) * | 2008-07-24 | 2011-12-01 | ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション,インコーポレイテッド | Therapies targeting cancer stem cells |
US9151760B2 (en) * | 2009-09-29 | 2015-10-06 | The Board Of Trustees Of The Leland Stanford Junior University | Isolation and use of melanoma cancer stem cells |
SG189302A1 (en) * | 2010-10-06 | 2013-05-31 | Pharmalogicals Res Pte Ltd | Cancer stem cell population and method for production thereof |
-
2013
- 2013-08-06 KR KR1020157006546A patent/KR20150041149A/en not_active Application Discontinuation
- 2013-08-06 JP JP2015527487A patent/JP2015526087A/en active Pending
- 2013-08-06 CA CA2882095A patent/CA2882095A1/en not_active Abandoned
- 2013-08-06 GB GB201503604A patent/GB2519717A/en not_active Withdrawn
- 2013-08-06 WO PCT/US2013/053850 patent/WO2014028274A1/en active Application Filing
- 2013-08-06 SG SG11201501195RA patent/SG11201501195RA/en unknown
- 2013-08-06 AU AU2013303012A patent/AU2013303012B2/en not_active Ceased
- 2013-08-06 US US14/421,413 patent/US20150238586A1/en not_active Abandoned
- 2013-08-06 CN CN201380053912.9A patent/CN105051187A/en active Pending
- 2013-08-06 EP EP13829340.2A patent/EP2885403A4/en not_active Withdrawn
-
2015
- 2015-02-12 IL IL237205A patent/IL237205A0/en unknown
- 2015-11-13 HK HK15111210.4A patent/HK1210498A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2882095A1 (en) | 2014-02-20 |
HK1210498A1 (en) | 2016-04-22 |
GB2519717A (en) | 2015-04-29 |
EP2885403A1 (en) | 2015-06-24 |
US20150238586A1 (en) | 2015-08-27 |
WO2014028274A1 (en) | 2014-02-20 |
EP2885403A4 (en) | 2016-04-13 |
CN105051187A (en) | 2015-11-11 |
KR20150041149A (en) | 2015-04-15 |
GB201503604D0 (en) | 2015-04-15 |
IL237205A0 (en) | 2015-04-30 |
JP2015526087A (en) | 2015-09-10 |
AU2013303012B2 (en) | 2017-04-27 |
AU2013303012A1 (en) | 2015-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1210498A1 (en) | Rapid method production high purity cancer stem cells and population of high purity cancer stem cells | |
SG11201604584QA (en) | In vitro production of foregut stem cells | |
HK1210494A1 (en) | Devices and methods for culture of cells | |
SG11201404677TA (en) | Process of expanding t cells | |
EP2626414A4 (en) | Cancer stem cell mass and process for production thereof | |
EP2859136A4 (en) | Gas permeable electrode and method of manufacture | |
EP2861612A4 (en) | Methods of preparing pluripotent stem cells | |
GB2500825B (en) | Alloy and method of production thereof | |
EP2968549A4 (en) | Methods of cell culture | |
GB201117522D0 (en) | Visor and method of manufacture | |
EP2971040A4 (en) | Methods of cell culture | |
EP2971014A4 (en) | Methods of cell culture | |
PT2825503T (en) | Method and system for the production of hydrogen | |
EP2805350A4 (en) | Memory cells and methods of forming memory cells | |
EP2766179A4 (en) | Arrays and methods of manufacture | |
EP2912166A4 (en) | Methods of producing pluripotent stem cells from chondrocytes | |
EP2913396A4 (en) | Method of manufacturing differentiated pluripotent stem cell | |
PL2658960T3 (en) | Improved production processes of haematococcus cell components | |
IL239646A0 (en) | Process for the large scale production of fruit cells and treatment of diseases with such cells | |
EP2768029A4 (en) | Multi-quantum well solar cell and method of manufacturing multi-quantum well solar cell | |
HK1202183A1 (en) | Solar cells and methods of fabrication thereof | |
ZA201403568B (en) | Shape optimized headers and methods of manufacture thereof | |
SG11201510462QA (en) | Method of culturing cancer stem cells | |
EP2912694A4 (en) | Methods of forming solar cells | |
SG11201408696PA (en) | Carbon crucible and method of manufacturing same |